- Home
- PULM vs NDLS Comparison
PULM vs NDLS Comparison
Compare PULM & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- NDLS
- Stock Information
- Founded
- PULM 2003
- NDLS 1995
- Country
- PULM United States
- NDLS United States
- Employees
- PULM N/A
- NDLS N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- NDLS Restaurants
- Sector
- PULM Health Care
- NDLS Consumer Discretionary
- Exchange
- PULM Nasdaq
- NDLS Nasdaq
- Market Cap
- PULM 33.2M
- NDLS 32.9M
- IPO Year
- PULM N/A
- NDLS 2013
- Fundamental
- Price
- PULM $6.10
- NDLS $0.90
- Analyst Decision
- PULM
- NDLS Strong Buy
- Analyst Count
- PULM 0
- NDLS 2
- Target Price
- PULM N/A
- NDLS $3.00
- AVG Volume (30 Days)
- PULM 58.4K
- NDLS 220.4K
- Earning Date
- PULM 08-12-2025
- NDLS 08-06-2025
- Dividend Yield
- PULM N/A
- NDLS N/A
- EPS Growth
- PULM N/A
- NDLS N/A
- EPS
- PULM N/A
- NDLS N/A
- Revenue
- PULM $1,921,000.00
- NDLS $495,670,000.00
- Revenue This Year
- PULM N/A
- NDLS $5.37
- Revenue Next Year
- PULM $134.88
- NDLS $0.68
- P/E Ratio
- PULM N/A
- NDLS N/A
- Revenue Growth
- PULM N/A
- NDLS N/A
- 52 Week Low
- PULM $1.78
- NDLS $0.55
- 52 Week High
- PULM $10.40
- NDLS $1.83
- Technical
- Relative Strength Index (RSI)
- PULM 37.74
- NDLS 58.29
- Support Level
- PULM $6.28
- NDLS $0.80
- Resistance Level
- PULM $6.83
- NDLS $0.82
- Average True Range (ATR)
- PULM 0.44
- NDLS 0.09
- MACD
- PULM -0.08
- NDLS 0.02
- Stochastic Oscillator
- PULM 0.00
- NDLS 89.73
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.